trending Market Intelligence /marketintelligence/en/news-insights/trending/uFBsWsCr6SLCIkl-KkCpPA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

CEO: Centene close to securing all regulatory approvals for WellCare deal

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

CEO: Centene close to securing all regulatory approvals for WellCare deal

Centene Corp. Chairman and CEO Michael Neidorff disclosed that his company has received conditional approvals for its pending acquisition of WellCare Health Plans Inc. from every relevant state except Illinois and New Jersey.

The managed care insurer is confident that it will receive all the necessary approvals to close the transaction by the first half of 2020.

"Given the progress of activities to date, there may be an opportunity to close earlier" in that year, Neidorff said on a third-quarter earnings conference call.

Neidorff also said he was disappointed Centene was not selected for a Medicaid contract in Louisiana. After reviewing the scoring and evaluation process, Centene filed a protest against the state. Louisiana is considering using emergency contracts with the incumbents to avoid member disruption until the appeal is resolved, the executive said.

Centene updated its GAAP diluted EPS projection for 2019 and its tax rate to reflect the impairment charge and the refinancing cost that would be incurred in the fourth quarter. It now expects full-year GAAP EPS to come in between $3.04 and $3.21, down from the prior estimate of $3.70 to $3.87.

The company also announced in its earnings release that its board signed off on a $500 million increase to its stock repurchase program. CFO Jeffrey Schwaneke on the call said buybacks could be used to help reduce debt and help with accretion. Given where the stock is trading, upping the repurchase plan "just makes sense," he added.